#Humantec
LightNews LightNews
kstrategyand.bsky.social
🚀 Weekly Roundup - PHARMA - 27 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#AstraZeneca #Calquence #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec
Weekly Roundup - PHARMA - 27 January 2025
🔊AstraZeneca's Calquence Gets Full FDA Approval for Mantle Cell Lymphoma Calquence becomes the first BTK inhibitor approved for first-line treatment of mantle cell lymphoma, offering a 27% progression...
www.linkedin.com
January 27, 2025 at 10:58 AM
kstrategyand.bsky.social
Weekly Roundup - DIGITAL HEALTH/DTx - 3 December 2024

➡ www.linkedin.com/pulse/weekly...

#DigitalHealth #HealthTech #Telemedicine #Telehealth #mHealth #HealthIT #eHealth #DigitalMedicine #DTx #MedTech #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - DIGITAL HEALTH/DTx - 3 December 2024
Philips Secures FDA Clearance for Cutting-Edge Remote Imaging and Protocol Management Tools Philips has received FDA 510(k) clearance for remote scanning and protocol management capabilities on its Ra...
www.linkedin.com
December 9, 2024 at 9:08 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/cisco-...

Cisco Launches Groundbreaking Virtual Hospital Research Framework in Ireland

kstrategyand.com

#Cisco #VirtualHospital #DigitalHealthcare #AIInHealthcare #HealthOutcomes #Humanteconomy #Humantec #KStrategyand
Cisco Launches Groundbreaking Virtual Hospital Research Framework in Ireland
Cisco, in collaboration with the University of Galway and CÚRAM, SFI Research Centre for Medical Devices, has unveiled a revolutionary Virtual Hospital research framework in Ireland, marking a signifi...
www.linkedin.com
December 20, 2024 at 10:59 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/digita...

Digital Therapeutics Enhance Mental Health Outcomes at Froedtert & MCW Health Network

#DigitalTherapeutics #MentalHealth #BehavioralHealth #PatientCare #AccessToCare #DigitalMentalHealth #SilverCloud #Humanteconomy #Humantec
Digital Therapeutics Enhance Mental Health Outcomes at Froedtert & MCW Health Network
Froedtert & the Medical College of Wisconsin (MCW) Health Network has made significant strides in improving mental health outcomes through the use of digital therapeutics (DTx), which help enhance acc...
www.linkedin.com
December 13, 2024 at 11:15 AM
kstrategyand.bsky.social
Weekly Roundup - DIGITAL HEALTH/DTx - 14 January 2025

www.linkedin.com/pulse/weekly...

➡ kstrategyand.com/digital-heal...

#FDA #AI #UK #NHSApp #Lincolnshire #SkillnetIreland #UCDavisHealth #Myant #mmHgInc #CapricornPartners #DigitalMedicine #DTx #MedTech #Humanteconomy #Humantec #KStrategyand
January 15, 2025 at 3:38 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/abbvie...

AbbVie Acquires Nimble Therapeutics in $200M Deal to Strengthen Immunology Pipeline

kstrategyand.com/pharma-news

#AbbVie #NimbleTherapeutics #Immunology #AutoimmuneDiseases #Skyrizi #Rinvoq #InflammatoryBowelDiseases #Neuroscience#Humanteconomy #Humantec
AbbVie Acquires Nimble Therapeutics in $200M Deal to Strengthen Immunology Pipeline
AbbVie has announced its acquisition of Nimble Therapeutics for $200 million upfront, marking another significant move in the pharma giant's strategic efforts to bolster its long-term growth prospects...
www.linkedin.com
December 26, 2024 at 11:21 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/nxera-...

Nxera and Shionogi Deliver Innovation with QUVIVIQ™ Launch, Targeting Japan's Insomnia Epidemic

kstrategyand.com/pharma-news

#NxeraPharma #Shionogi #QUVIVIQ #Daridorexant #InsomniaTreatment #SleepHealth #MentalHealthSupport #Humanteconomy #Humantec
Nxera and Shionogi Deliver Innovation with QUVIVIQ™ Launch, Targeting Japan's Insomnia Epidemic
Nxera Pharma Co., Ltd.
www.linkedin.com
December 26, 2024 at 11:14 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/explor...

Exploring Immersive Digital Therapeutics in Clinical Settings: Enhancing Outcomes, Streamlining Operations, and Navigating Regulatory Pathways

#MentalHealthSolutions #Rejoyn #DaylightRx #Humanteconomy #Humantec #KStrategyand
Exploring Immersive Digital Therapeutics in Clinical Settings: Enhancing Outcomes, Streamlining Operations, and Navigating Regulatory Pathways
Immersive digital therapeutics (DTx) are reshaping the healthcare landscape by enhancing patient outcomes, optimizing clinical operations, and addressing key regulatory challenges. By integrating adva...
www.linkedin.com
December 13, 2024 at 11:25 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/neogap...

NEOGAP Therapeutics Earns EMA ATMP Classification for Groundbreaking Personalized Cancer Cell Therapy

#NEOGAPTherapeutics #TCellExpansion #InnovativeTherapies#Humanteconomy #Humantec #KStrategyand
NEOGAP Therapeutics Earns EMA ATMP Classification for Groundbreaking Personalized Cancer Cell Therapy
NEOGAP Therapeutics, a Swedish clinical-stage biotechnology company, has received a major regulatory milestone with the European Medicines Agency (EMA) granting Advanced Therapy Medicinal Product (ATM...
www.linkedin.com
December 15, 2024 at 10:11 AM
kstrategyand.bsky.social
🚀 Weekly Roundup - PHARMA - 20 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#AutolusTherapeutics #BannerLifeSciences #Bafiertam #Pfizer #Sasanlimab #TyraBiosciences #ImmunoForge #Pemziviptadil #PharmaNews #ClinicalTrials #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - PHARMA - 20 January 2025
🔊Autolus Therapeutics Secures FDA Approval for Aucatzyl Cell Therapy in Relapsed B-Cell Leukemia Autolus Therapeutics is launching Aucatzyl commercially in the U.S.
www.linkedin.com
January 20, 2025 at 12:02 PM
kstrategyand.bsky.social
Weekly Roundup - PHARMA - 9 December 2024

www.linkedin.com/pulse/pharma...

➡ kstrategyand.com/pharma-news

#BioconBiologics #Yesintek #BPZE1 #Roche #SanDiegoBiotech #PTC #Novartis #HuntingtonsDiseaseDrug #GSK #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec
PHARMA - 9 December 2024
🔊Biocon Biologics' Yesintek Receives Green Light From FDA YESINTEK™ is approved for use in Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis, offering a biosimilar option ...
www.linkedin.com
December 9, 2024 at 11:23 AM
kstrategyand.bsky.social
Weekly Roundup - DIGITAL HEALTH/DTx - 24 December 2024

www.linkedin.com/pulse/weekly...

kstrategyand.com/digital-heal...

#DiMe #ConnectedHealthCollaborative #Ireland #VirtualHospitals #electronRx #PurpleDx #DUOS #mHealth #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - DIGITAL HEALTH/DTx - 24 December 2024
DiMe Unveils the Connected Health Collaborative Community Initiative The Digital Medicine Society (DiMe) has launched the Connected Health Collaborative Community (CHcc) project, co-hosted with the Co...
www.linkedin.com
December 24, 2024 at 11:25 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/mindme...

MindMed’s MM120 ODT Gains UK Innovation Passport for Generalized Anxiety Disorder Treatment

kstrategyand.com

#InnovationPassport #MindMed #MM120 #GeneralizedAnxietyDisorder #GAD #MentalHealthInnovation #HealthcareInnovation #Humanteconomy #Humantec #KStrategyand
MindMed’s MM120 ODT Gains UK Innovation Passport for Generalized Anxiety Disorder Treatment
Mind Medicine Inc. (MindMed), a clinical-stage biopharmaceutical company, has achieved a significant milestone with the Innovation Passport designation granted by the United Kingdom’s Innovative Licen...
www.linkedin.com
December 19, 2024 at 10:52 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/novo-n...

Novo Nordisk's Ozempic®: A Groundbreaking Leap in Kidney Disease Management

kstrategyand.com

#NovoNordisk #Ozempic #KidneyHealth #Type2Diabetes #ChronicKidneyDisease #FLOWTrial #CardiovascularHealth #InnovativeMedicine #Humanteconomy #Humantec #KStrategyand
Novo Nordisk's Ozempic®: A Groundbreaking Leap in Kidney Disease Management
Novo Nordisk has reached another milestone in the fight against chronic illnesses with the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopting a positive opinion...
www.linkedin.com
December 20, 2024 at 11:11 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/lilly-...

Lilly Expands Inflammatory Bowel Disease Portfolio with FDA Nod for Omvoh® in Crohn's

#Omvoh #EliLilly #CrohnsDisease #IBD #MedicalBreakthrough #ChronicIllness #Inflammation #PatientCare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand
Lilly Expands Inflammatory Bowel Disease Portfolio with FDA Nod for Omvoh® in Crohn's
Eli Lilly’s Omvoh® (mirikizumab-mrkz) has gained a significant regulatory nod, securing FDA approval for the treatment of moderately to severely active Crohn’s disease in adults. This marks a pivotal ...
www.linkedin.com
January 27, 2025 at 4:34 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/eli-li...

Eli Lilly Joins Forces with Scorpion Therapeutics in $2.5 Billion Cancer Drug Deal

kstrategyand.com/pharma-news

#EliLilly #ScorpionTherapeutics #MedicalInnovation #Healthcare #PharmaPartnerships #Verzenio #BiotechNews #Humanteconomy #Humantec #KStrategyand
Eli Lilly Joins Forces with Scorpion Therapeutics in $2.5 Billion Cancer Drug Deal
Eli Lilly and Co. is making waves in the oncology world with its bold move to acquire Scorpion Therapeutics' experimental PI3K inhibitor for a staggering $2.
www.linkedin.com
January 23, 2025 at 11:17 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/glooko...

Glooko and Hedia Join Forces for Smarter Insulin Dosing in Diabetes Management

kstrategyand.com/digital-heal...

#DiabetesCare #GlookoHedia #DigitalHealth #InsulinManagement #Type1Diabetes #PersonalizedMedicine #HealthTech #Humanteconomy #Humantec #KStrategyand
Glooko and Hedia Join Forces for Smarter Insulin Dosing in Diabetes Management
In an exciting development for diabetes care, Glooko, Inc. and Hedia have launched an interoperable solution that promises to transform the management of Type 1 and Type 2 diabetes.
www.linkedin.com
January 15, 2025 at 10:44 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/nhs-re...

NHS Reform: Empowering Patients to Control Waiting Times and Treatment Choices

kstrategyand.com/pharma-news

#NHSReform #PatientEmpowerment #HealthTech #DigitalHealth #ElectiveCare #NHSPlan #Humanteconomy #Humantec #KStrategyand
NHS Reform: Empowering Patients to Control Waiting Times and Treatment Choices
The government has unveiled a bold new approach to tackle NHS waiting lists, placing greater power in the hands of patients. Through a series of transformative changes, including an upgraded NHS App, ...
www.linkedin.com
January 10, 2025 at 10:57 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/electr...

electronRx to Launch purpleDx App for Remote Monitoring of Lung Function at CES 2025

kstrategyand.com

#purpleDx #electronRx #LungHealth #ChronicRespiratoryDisease #RemoteMonitoring #DigitalMedicine #ChronicDiseaseManagement #Humanteconomy #Humantec #KStrategyand
electronRx to Launch purpleDx App for Remote Monitoring of Lung Function at CES 2025
purpleDx is designed to be a user-friendly cardiopulmonary assessment tool that empowers both patients and healthcare providers. The app allows individuals suffering from chronic respiratory condition...
www.linkedin.com
December 20, 2024 at 11:18 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/mayo-c...

Mayo Clinic Teams Up with NVIDIA and Aignostics to Transform Pathology with Digital Innovation

kstrategyand.com/digital-heal...

#MayoClinic #DigitalPathology #AIinHealthcare #MedicalInnovation #FasterDiagnoses #Humanteconomy #Humantec #KStrategyand
Mayo Clinic Teams Up with NVIDIA and Aignostics to Transform Pathology with Digital Innovation
Mayo Clinic is once again leading the charge in healthcare innovation with the launch of Mayo Clinic Digital Pathology, a transformative initiative designed to revolutionize the field of pathology. Th...
www.linkedin.com
January 17, 2025 at 9:49 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/noema-...

Noema Pharma Raises CHF 130 Million in Series B Extension to Advance Breakthrough CNS Treatments

kstrategyand.com/pharma-news

#NoemaPharma #CNSDisorders #Neuroscience #SeriesBFunding #EQTLifeSciences #Neurotherapeutics #Humanteconomy #Humantec #KStrategyand
Noema Pharma Raises CHF 130 Million in Series B Extension to Advance Breakthrough CNS Treatments
Noema Pharma, a clinical-stage biotech company focused on developing innovative treatments for central nervous system (CNS) disorders, has successfully closed an extension of its Series B financing ro...
www.linkedin.com
January 13, 2025 at 9:24 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/jp-mor...

JP Morgan Healthcare Conference: J&J, Eli Lilly, and GSK Spark M&A Revival in 2025

kstrategyand.com/pharma-news

#HealthcareMergers #PharmaDeals #GSK #MergersAndAcquisitions #BiotechNews #Neuroscience #Oncology #Healthcare2025 #Humanteconomy #Humantec #KStrategyand
JP Morgan Healthcare Conference: J&J, Eli Lilly, and GSK Spark M&A Revival in 2025
The financial hub of San Francisco buzzed with anticipation as the prestigious JP Morgan Healthcare Conference unfolded, setting the stage for a series of transformative announcements that could resha...
www.linkedin.com
January 23, 2025 at 11:09 AM
kstrategyand.bsky.social
www.linkedin.com/pulse/uk-hea...

UK Health Department Invests £86M in Integrated Digital Medical Records Across NHS and Social Care

kstrategyand.com/digital-heal...

#NHSInnovation #DigitalHealthcare #HealthTechnology #Humanteconomy #Humantec #KStrategyand
UK Health Department Invests £86M in Integrated Digital Medical Records Across NHS and Social Care
The UK Department for Health and Social Care (DHSC) has announced plans to develop a shared digital platform that will allow NHS and care staff to seamlessly access up-to-date medical information. Thi...
www.linkedin.com
January 16, 2025 at 10:55 AM
kstrategyand.bsky.social
Weekly Roundup - PHARMA - 10 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#Celltrion #Avtozma #Axsome #Symbravo #Anzupgo #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - PHARMA - 10 February 2025
🔊Celltrion’s Avtozma Wins FDA Approval for Autoimmune & Inflammatory Diseases Avtozma, an Actemra biosimilar, is approved in both IV and SC forms, backed by a Phase III trial confirming its similarity...
www.linkedin.com
February 12, 2025 at 4:22 AM
kstrategyand.bsky.social
Weekly Roundup - DIGITAL HEALTH/DTx - 11 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/digital-heal...

#HighmarkHealth #Stanza #DigitalHealth #HealthTech #Telemedicine #Telehealth #mHealth #HealthIT #eHealth #DigitalMedicine #DTx #MedTech #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - DIGITAL HEALTH/DTx - 11 February 2025
Highmark Health Expands Access to Stanza, FDA-Cleared Digital Therapy for Fibromyalgia Swing Therapeutics' digital treatment for fibromyalgia, Stanza, has received a positive coverage decision from Hi...
www.linkedin.com
February 12, 2025 at 4:07 AM